| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/28/2011 | US7968560 Compounds that modulate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprising said compounds |
| 06/28/2011 | US7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/28/2011 | US7968531 Use of 2,5-dihydroxybenzenesulphonic acid in the production of medicaments for the treatment of angiodependent diseases such as cancer and psoriasis |
| 06/28/2011 | US7968528 Choline-silicic acid complex with osmolytes and divalent trace elements |
| 06/28/2011 | US7968523 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides |
| 06/28/2011 | US7968284 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 06/28/2011 | CA2563800C Spinosyns for wound healing |
| 06/28/2011 | CA2383841C Chemical peeling agent |
| 06/23/2011 | WO2011075628A1 Heterocyclic compounds and their uses |
| 06/23/2011 | WO2011075267A1 Use of alpha 2 adrenergic receptor agonists for treating or preventing psoriasis |
| 06/23/2011 | WO2011074921A2 Composition for alleviating atopic dermatitis and a preparation method of the same |
| 06/23/2011 | WO2011074643A1 Prophylactic or ameliorating agent fo pigmentation |
| 06/23/2011 | WO2011074275A1 Skin barrier function promoter |
| 06/23/2011 | WO2011073961A1 Process for obtaining a standardised extract of quercetin and 3-0-methylquercetin from flowers of macela (achyrocline satureioides), and cosmetic and pharmaceutical compositions comprising said extract |
| 06/23/2011 | WO2011073437A2 Bacteriocin- and prebiotic-based cosmetic or dermatological compositions |
| 06/23/2011 | WO2011073281A1 Composition containing at least one c7 sugar for alopecia treatment, cosmetic treatment of hair and nails, and care of hair, eyelashes, or nails |
| 06/23/2011 | WO2011073248A1 Use of compounds in the treatment or prevention of skin disorders |
| 06/23/2011 | WO2011072394A1 METHOD OF TREATING SCARS AND ß-CATENIN-MEDIATED DISORDERS USING NEFOPAM COMPOUNDS |
| 06/23/2011 | WO2011048554A3 Combination of a probiotic lysate and a c-glycoside derivative |
| 06/23/2011 | WO2011014588A3 Dermal formulations of dp2 receptor antagonists |
| 06/23/2011 | US20110154521 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 06/23/2011 | US20110152746 Methods for generating new hair follicles, treating baldness, and hair removal |
| 06/23/2011 | US20110152382 Composition of molecular elements for phosphorylase kinase inhibition |
| 06/23/2011 | US20110152379 Composition for control of aging and/or extension of life, containing dapsone as active ingredient |
| 06/23/2011 | US20110152373 Hair growth promoting agent containing 15,15-difluoroprostaglandin f2alpha derivative as active ingredient |
| 06/23/2011 | US20110152372 Anhydrous petroleum jelly/elastomer-free depigmenting compositions comprising a solubilized phenolic compound and a retinoid |
| 06/23/2011 | US20110152366 N-alkylcarbonyl-amino acid ester compounds and their use for skin irritation, itch, and pain |
| 06/23/2011 | US20110152341 Cleavage of b-amyloid precursor protein |
| 06/23/2011 | US20110152338 Cycloalkane[b]indole antagonists of prostaglandin d2 receptors |
| 06/23/2011 | US20110152335 Allantoin-containing skin cream |
| 06/23/2011 | US20110152330 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 06/23/2011 | US20110152318 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same |
| 06/23/2011 | US20110152305 Films and particles |
| 06/23/2011 | US20110152296 Heterocyclic compounds and their uses |
| 06/23/2011 | US20110152292 Salts comprising a pyrimidinecarboxylic acid derivative for cosmetic use |
| 06/23/2011 | US20110152291 Novel aromatic compounds and their use in medical applications |
| 06/23/2011 | US20110152290 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| 06/23/2011 | US20110152282 Hedgehog pathway modulators |
| 06/23/2011 | US20110152277 Heterocyclic compounds and their uses |
| 06/23/2011 | US20110152276 Substituted pyrrolo[2,3-d]pyrimidines as antifolates |
| 06/23/2011 | US20110152273 Fused heteroaromatic pyrrolidinones |
| 06/23/2011 | US20110152260 Indazole derivatives as modulators of interleukin-1 receptor-associated kinase |
| 06/23/2011 | US20110152255 Therapeutic compounds |
| 06/23/2011 | US20110152243 Novel thienopyrrole compounds |
| 06/23/2011 | US20110152242 2,3-Substituted Fused Pyrimidin -4 (3H)-Ones as VR1 Antagonists |
| 06/23/2011 | US20110152241 Novel compounds as receptor modulators with therapeutic utility |
| 06/23/2011 | US20110152238 Pharmaceutical compounds |
| 06/23/2011 | US20110152228 Sprayable pharmaceutical compositions comprising a corticoid and an oily phase |
| 06/23/2011 | US20110152222 Use of 2,5-dihydroxybenzene derivatives for the treatment of arthritis and pain |
| 06/23/2011 | US20110152218 Crystalline phospholipid, method for its production and use in treating damaged tissue |
| 06/23/2011 | US20110152212 Aqueous Formulations |
| 06/23/2011 | US20110152202 Development of c-reactive protein mutant with improved therapeutic benefit in immune thrombocytopenia and lupus nephritis |
| 06/23/2011 | US20110152197 Analgesic effects of peptide toxin apetx2 |
| 06/23/2011 | US20110152189 Methods for the inhibition of scarring |
| 06/23/2011 | US20110152187 Insulin-like growth factor fusion proteins |
| 06/23/2011 | US20110152173 TNF-a ANTAGONIST MULTI-TARGET BINDING PROTEINS |
| 06/23/2011 | US20110152171 Histamine binding protein |
| 06/23/2011 | US20110152169 Sparc anti-inflammatory activity and uses thereof |
| 06/23/2011 | US20110152083 Network copolymer crosslinked compositions and products comprising the same |
| 06/23/2011 | US20110151480 Methods of purifying zsig33 |
| 06/23/2011 | US20110151472 Novel means for the diagnosis and therapy of ctcl |
| 06/23/2011 | US20110151434 Adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 06/23/2011 | US20110151032 Topical anti-inflammatory combination |
| 06/23/2011 | US20110151031 Compositions and methods for utilizing the same |
| 06/23/2011 | US20110151029 Paxillin Stimulating Compositions and Cosmetic Uses Thereof |
| 06/23/2011 | US20110151016 Use of angiogenin or angiogenin agonists for treating diseases and disorders |
| 06/23/2011 | US20110151011 Decellularized Adipose Tissue |
| 06/23/2011 | US20110151009 Use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy |
| 06/23/2011 | US20110151005 Methods and means for soft tissue engineering |
| 06/23/2011 | US20110151000 Nitric oxide-releasing compositions, devices and methods |
| 06/23/2011 | US20110150998 Methods For Producing ECM-Based Biomaterials |
| 06/23/2011 | US20110150981 Compounds for Use in Therapy |
| 06/23/2011 | US20110150943 Adhesive for medical applications and means for haemostasis |
| 06/23/2011 | US20110150894 Methods of modulating angiogenesis via trpv4 |
| 06/23/2011 | US20110150893 Anti-trkb monoclonal antibodies and uses thereof |
| 06/23/2011 | US20110150890 Use of cgrp antagonist compounds for treatment of psoriasis |
| 06/23/2011 | US20110150873 Anti-inflammatory compositions and combinations |
| 06/23/2011 | US20110150872 Soluble heterodimeric cytokine receptor |
| 06/23/2011 | US20110150865 Antibodies to lymphotoxin-alpha |
| 06/23/2011 | US20110150863 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 06/23/2011 | US20110150856 Compositions and methods for treatment of vitiligo |
| 06/23/2011 | US20110150853 Mycotoxin-reducing composition |
| 06/23/2011 | US20110150846 Compositions and methods for tissue filling and regeneration |
| 06/23/2011 | US20110150844 Compositions and methods for controlling proliferation and differentiation of cells |
| 06/23/2011 | US20110150834 Crth2 modulators |
| 06/23/2011 | US20110150831 Novel naphthyridine derivatives and the use thereof as kinase inhibitors |
| 06/23/2011 | US20110150825 Uses of selective inhibitors of hdac8 for treatment of inflammatory conditions |
| 06/23/2011 | US20110150796 Precipitation polymerization in the presence of glycerin monostearate |
| 06/23/2011 | US20110150774 Screening for modulators of ces1 and/or ces3 for the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 06/23/2011 | US20110150773 Modulators of acetyl-coenzyme a acyltransferase 1 or 2 in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 06/23/2011 | US20110150772 Modulators of carnitine octanoyltransferase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 06/23/2011 | US20110150765 Frozen compositions and methods for piercing a substrate |
| 06/23/2011 | US20110147259 Stabilized Glycerin-in-Oil Emulsions |
| 06/23/2011 | CA2784785A1 Methods and compositions for treating inflammation of skin |
| 06/23/2011 | CA2784566A1 Heterocyclic compounds and their uses |
| 06/23/2011 | CA2784308A1 Preventing or ameliorating agent for pigmentation |
| 06/23/2011 | CA2783696A1 Use of compounds in the treatment or prevention of skin disorders |
| 06/23/2011 | CA2782472A1 Method of treating scars and beta-catenin-mediated disorders |
| 06/23/2011 | CA2781112A1 Use of alpha 2 adrenergic receptor agonists for treating or preventing psoriasis |
| 06/22/2011 | EP2336321A1 Ox2 receptor homolog |